Theoretical calculation and prediction of P-glycoprotein-interacting drugs using MolSurf parametrization and PLS statistics

被引:68
作者
Österberg, T [1 ]
Norinder, U [1 ]
机构
[1] AstraZeneca R&D Sodertalje, SE-15185 Sodertalje, Sweden
关键词
MolSurf; PLS; p-glycoprotein; multidrug resistance; quantum mechanics;
D O I
10.1016/S0928-0987(00)00077-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A method for the modelling and prediction of P-glycoprotein-associated ATPase activity using theoretically computed molecular descriptors and multivariate statistics has been investigated using 22 diverse drug-like compounds. The program MolSurf was used to compute theoretical molecular descriptors related to physicochemical properties such as lipophilicity, polarity, polarizability and hydrogen bonding. The multivariate partial least squares projections to latent structures (PLS) method was used to delineate the relationship between the P-glycoprotein-associated ATPase activity and the theoretically computed molecular descriptors. The PLS analysis of the entire data set, with the exclusion of tamoxifen, resulted in one significant PLS component according to cross-validation with R-2=0.718, Q(2)=0.695, S.D. =0.475, F=48.37, RMSEtr=0.452, p<0.001. Properties associated with the size of the molecular surface, polarizability and hydrogen bonding had the largest impact on the P-glycoprotein-associated ATPase activity. All these properties should be high to promote high ATPase activity. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 28 条
[1]   DISCRETE MUTATIONS INTRODUCED IN THE PREDICTED NUCLEOTIDE-BINDING SITES OF THE MDR1 GENE ABOLISH ITS ABILITY TO CONFER MULTIDRUG RESISTANCE [J].
AZZARIA, M ;
SCHURR, E ;
GROS, P .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (12) :5289-5297
[2]  
Bain LJ, 1997, ENVIRON HEALTH PERSP, V105, P812, DOI 10.2307/3433698
[3]   Mechanisms of multidrug transporters [J].
Bolhuis, H ;
vanVeen, HW ;
Poolman, B ;
Driessen, AJM ;
Konings, WN .
FEMS MICROBIOLOGY REVIEWS, 1997, 21 (01) :55-84
[4]  
GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163
[5]  
Jackson JE, 1991, A user's guide to principal components
[6]  
Joliffe I.T., 1986, Principal Component Analysis
[7]   Drug transfer across the blood-brain barrier and improvement of brain delivery [J].
Jolliet-Riant, P ;
Tillement, JP .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (01) :16-26
[8]   TRANSPORT OF CELIPROLOL ACROSS HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS - MEDIATION OF SECRETION BY MULTIPLE TRANSPORTERS INCLUDING P-GLYCOPROTEIN [J].
KARLSSON, J ;
KUO, SM ;
ZIEMNIAK, J ;
ARTURSSON, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1009-1016
[9]  
Kim AE, 1998, J PHARMACOL EXP THER, V286, P1439
[10]   Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity [J].
Litman, T ;
Zeuthen, T ;
Skovsgaard, T ;
Stein, WD .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (02) :159-168